Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/23/1990 | US4965353 Polysaccharide esters and their salts |
10/23/1990 | US4965262 Administering ofloxacin |
10/23/1990 | US4965253 Viscoelastic material for ophthalmic surgery |
10/23/1990 | US4965252 Cholesterol-lowering combination compositions of guar gum and niacin |
10/23/1990 | US4965128 Hollow fibers; sustained release |
10/23/1990 | US4965089 High speed dipping |
10/23/1990 | US4965074 Transdermally administering nicotine or its analogs |
10/23/1990 | US4965072 Granulating composition and method |
10/23/1990 | US4965066 Intranasal administration of 3,3-disubstituted indolines |
10/23/1990 | CA1275533C Magnetic-polymer particles |
10/23/1990 | CA1275380C Composition for oral application |
10/20/1990 | CA2014926A1 Oral preparation |
10/19/1990 | WO1990012595A1 Liposomal targeting of ischemic tissue |
10/19/1990 | WO1990012566A1 Method of producing flavoring oral preparation |
10/19/1990 | CA2031206A1 Process for producing flavored pharmaceutical preparation for oral administration |
10/18/1990 | WO1990012572A1 Stable ascorbic acid compositions |
10/18/1990 | WO1990011856A1 Density element and method of manufacture thereof |
10/18/1990 | WO1990011781A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions |
10/18/1990 | WO1990011757A1 Sustained-release oral drug dosage form |
10/18/1990 | WO1990011756A1 Slow release vitreous systems |
10/18/1990 | WO1990011755A1 MONOCRYSTALS OF β-PHENYLPROPIOPHENONES |
10/18/1990 | WO1990011754A1 Aerosolized azole antifungals |
10/18/1990 | WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
10/18/1990 | DE3912433A1 Homogeneous aq. soln. of hypericin or derivs. prodn. - by dissolving solid in organic solvent then dilution to predetermined active ingredient content |
10/18/1990 | CA2014679A1 Antitumor agent indicated for lung cancer |
10/17/1990 | EP0392845A2 Solid gel external drug delivery system |
10/17/1990 | EP0392745A2 Immunoconjugates and prodrugs and their use in association for drug delivery |
10/17/1990 | EP0392487A2 Stabilized composition of anthracyclines |
10/17/1990 | EP0392429A1 Psoralen-reagens |
10/17/1990 | EP0391962A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine |
10/17/1990 | EP0391959A1 Tri-scored drug tablet. |
10/17/1990 | EP0391893A1 Porous microspheres for drug delivery and methods for making same. |
10/17/1990 | EP0182007B1 Galenical form containing nifedipine, and process for its preparation |
10/17/1990 | EP0173729B1 Process for solubilizing active principles and pharmaceutical compositions thus obtained |
10/17/1990 | CN1046189A Sheep growth hormone |
10/17/1990 | CN1046169A Destructurized starch and making same |
10/17/1990 | CN1046098A Partially fused pellet as subcutaneous drug delivery |
10/17/1990 | CN1046097A Spray gel base and spray gel prepartion using thereof |
10/17/1990 | CN1046095A Deodorant compositions containing specific piroctone salts and perfumes |
10/17/1990 | CA2014437A1 Moisturizing vehicle for topical application of vitamin a acid |
10/16/1990 | US4963662 Fluorinated nucleosides and method for treating retrovirus infections therewith |
10/16/1990 | US4963656 Stable, retain moisture |
10/16/1990 | US4963555 Formulations of heterocyclic compounds |
10/16/1990 | US4963551 Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof |
10/16/1990 | US4963540 Orally administering suspension of micronized progesterone in polyunsaturated edible oil |
10/16/1990 | US4963526 Two phase coacervate system |
10/16/1990 | US4963368 Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids |
10/16/1990 | US4963367 Coacervate-based matrix containing medicament in encapsulated film; surface active phospholipids |
10/16/1990 | US4963365 Soluble core of diltiazem hydrochloride with coatings of ethyl cellulose, talc, group 2 stearate; outer coating of drug |
10/16/1990 | US4963364 Microencapsulated antitumor agent |
10/16/1990 | US4963363 Phospholipid delivery vehicle for aqueous-insoluble active ingredients |
10/16/1990 | US4963362 Freeze-dried liposome mixture containing cyclosporin |
10/16/1990 | US4963361 Analgesic and antiinflammatory agent in mixture with adhesives and antioxidant |
10/16/1990 | US4963360 Heat developed when exposed to air enhances absorption through skin |
10/16/1990 | US4963359 Lozenge containing medication; edible fat, oil or wax, hydrogenated starch hydrolyzates, emulsifiers |
10/16/1990 | US4963345 Buffered acidic solution containing a vasodilator |
10/16/1990 | US4963297 Spontaneous vesticulation of multilamellar liposomes |
10/16/1990 | US4963261 Formed by heat fusion of polymer particles; time-release agents; drug delivery |
10/16/1990 | US4963141 Dispensing system for administering beneficial agent formulation to ruminants |
10/16/1990 | US4963130 Intra-peritoneal perfusion of oxygenated fluorocarbon |
10/16/1990 | CA1275252C Effervescent acetylsalicylic acid tablets |
10/16/1990 | CA1275248C Method for preserving liposomes |
10/16/1990 | CA1275247C Process for the solubilization, at the time of use, of a lipophilic active principle in an aqueous solution for intravenous administration |
10/16/1990 | CA1275216C Medical device for pulsatile transdermal delivery of biologically activeagents |
10/14/1990 | CA2012543A1 Solid gel external drug delivery system |
10/13/1990 | CA2014377A1 Composition |
10/13/1990 | CA2014244A1 Stabilized composition of anthracyclines |
10/12/1990 | WO1990012029A1 Lyophilized peptide formulations |
10/12/1990 | CA2028848A1 Lyophilized peptide formulations |
10/12/1990 | CA2014418A1 Sustained release pharmaceutical preparations containing an analgesic and a decongestant |
10/12/1990 | CA2014401A1 Aerosolised azole anti fungals |
10/11/1990 | WO1990012585A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/11/1990 | DE4008995A1 Zahnpastenzusammensetzungen und verfahren zu deren zubereitung Toothpaste compositions and methods for their preparation |
10/11/1990 | DE3911069A1 Einkristalle von ss-phenylpropiophenonen Single crystals of ss-phenylpropiophenonen |
10/11/1990 | CA2028825A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/10/1990 | EP0391853A2 Destructurized starch and method of making same |
10/10/1990 | EP0391852A2 Pharmaceutical compositions |
10/10/1990 | EP0391803A1 Process for preparing alginate capsules particularly useful for cosmetics, apparatus for performing said process and cosmetic composition containing said capsules |
10/10/1990 | EP0391754A1 Healing-enhancing composition |
10/10/1990 | EP0391637A1 Fluorinated microemulsion as oxygen carrier |
10/10/1990 | EP0391518A2 Sustained-release pharmaceutical preparation |
10/10/1990 | EP0391444A2 Interleukin-1 Formulation |
10/10/1990 | EP0391374A2 Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products |
10/10/1990 | EP0391369A2 Medicinal emulsions |
10/10/1990 | EP0391342A1 Spray gel base and spray gel preparation using thereof |
10/10/1990 | EP0391172A1 Transdermal therapeutic system with an increased rate of flow of medicament and method for its manufacture |
10/10/1990 | EP0391002A2 Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid |
10/10/1990 | EP0390960A1 Extruded gelled products |
10/10/1990 | EP0390930A1 Stable aqueous preparation of active vitamin d 3 |
10/10/1990 | EP0390832A1 Medicinal preparation comprising the association of colistin, tobramycin and amphotericin b administered by atomization |
10/10/1990 | EP0390820A1 Sustained release of encapsulated molecules |
10/10/1990 | CN1045921A Direct compression cholestry ramine tablet and solvent-free coating thereof |
10/10/1990 | CA2011826A1 Film-forming emulsion containing iodine and methods of use |
10/09/1990 | USRE33375 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
10/09/1990 | US4962178 Novel polysiloxane-polyurethanes and contact lens thereof |
10/09/1990 | US4962091 Controlled release of macromolecular polypeptides |
10/09/1990 | US4962022 Storage and use of liposomes |
10/09/1990 | US4961932 For sustained release drug delivery |
10/09/1990 | US4961931 Method for the management of hyperplasia |
10/09/1990 | US4961927 Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate |